Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Novartis tests new arthritis drug in early human trial

NCT ID NCT07029555

Recruiting now Disease control Sponsor: Novartis Pharmaceuticals Source: ClinicalTrials.gov ↗

Summary

This early-stage study is testing a new drug called PIT565 for rheumatoid arthritis. Researchers want to see if it's safe and how it moves through the body in 57 adults with RA. This is the first time the drug is being tested in people with this condition.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RHEUMATOID ARTHRITIS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

Locations

  • Novartis Investigative Site

    RECRUITING

    CABA, C1181ACH, Argentina

  • Novartis Investigative Site

    RECRUITING

    Sofia, 1618, Bulgaria

  • Novartis Investigative Site

    RECRUITING

    Beijing, 100191, China

  • Novartis Investigative Site

    RECRUITING

    Beijing, 100730, China

  • Novartis Investigative Site

    RECRUITING

    Le Kremlin-Bicêtre, 94275, France

  • Novartis Investigative Site

    RECRUITING

    Jena, Thuringia, 07740, Germany

  • Novartis Investigative Site

    RECRUITING

    Mainz, 55131, Germany

  • Novartis Investigative Site

    RECRUITING

    Szeged, 6725, Hungary

  • Novartis Investigative Site

    RECRUITING

    Leiden, South Holland, 2333 CL, Netherlands

  • Novartis Investigative Site

    RECRUITING

    Cluj-Napoca, Cluj, 400006, Romania

  • Novartis Investigative Site

    RECRUITING

    Bucharest, 011658, Romania

  • Novartis Investigative Site

    RECRUITING

    Santiago Compostela, A Coruna, 15706, Spain

  • Novartis Investigative Site

    RECRUITING

    Barcelona, 08035, Spain

Conditions

Explore the condition pages connected to this study.

RHEUMATOID ARTHRITIS